Elixxer Ltd (V:ELXR) — Market Cap & Net Worth
Market Cap & Net Worth: Elixxer Ltd (ELXR)
Elixxer Ltd (V:ELXR) has a market capitalization of $328.10K (CA$453.56K) as of May 2, 2026. Listed on the V stock exchange, this Canada-based company holds position #30685 globally and #1661 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Elixxer Ltd's stock price CA$0.04 by its total outstanding shares 11338900 (11.34 Million). Analyse ELXR cash generation efficiency to see how efficiently the company converts income to cash.
Elixxer Ltd Market Cap History: 2015 to 2026
Elixxer Ltd's market capitalization history from 2015 to 2026. Data shows change from $104.82 Million to $328.10K (-42.14% CAGR).
Elixxer Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Elixxer Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
114.86x
Elixxer Ltd's market cap is 114.86 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $73.82 Million | $172.54K | -$16.53 Million | 427.84x | N/A |
| 2020 | $12.30 Million | $16.27K | -$9.78 Million | 756.12x | N/A |
| 2021 | $12.30 Million | $42.41K | -$3.66 Million | 290.10x | N/A |
| 2022 | $9.43 Million | $82.13K | -$14.17 Million | 114.86x | N/A |
Competitor Companies of ELXR by Market Capitalization
Companies near Elixxer Ltd in the global market cap rankings as of May 2, 2026.
Key companies related to Elixxer Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.09 |
Elixxer Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Elixxer Ltd's market cap moved from $104.82 Million to $ 328.10K, with a yearly change of -42.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$328.10K | -96.52% |
| 2025 | CA$9.43 Million | 0.00% |
| 2024 | CA$9.43 Million | 0.00% |
| 2023 | CA$9.43 Million | 0.00% |
| 2022 | CA$9.43 Million | -23.33% |
| 2021 | CA$12.30 Million | 0.00% |
| 2020 | CA$12.30 Million | -70.00% |
| 2019 | CA$41.01 Million | -44.44% |
| 2018 | CA$73.82 Million | -82.00% |
| 2017 | CA$410.12 Million | +1566.67% |
| 2016 | CA$24.61 Million | -76.53% |
| 2015 | CA$104.82 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Elixxer Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $328.10K USD |
| MoneyControl | $328.10K USD |
| MarketWatch | $328.10K USD |
| marketcap.company | $328.10K USD |
| Reuters | $328.10K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Elixxer Ltd
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cultivation, production, and/or sale of medical cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Mon… Read more